Neuberger Berman Group
AXSM icon

Neuberger Berman Group’s Axsome Therapeutics AXSM Stock Holding History

Neuberger Berman Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Sell
60,759
-8,724
-13% -$1.51M 0.01% 809
2025
Q4 		$12.7M Sell
69,483
-21,695
-24% -$3.03M 0.01% 756
2025
Q3 		$11.1M Buy
91,178
+20,546
+29% +$2.31M 0.01% 780
2025
Q2 		$7.37M Buy
+70,632
New +$7.48M 0.01% 861
2024
Q4 		– Sell
-80,014
Closed -$7.19M – 1935
2024
Q3 		$7.19M Buy
80,014
+5,247
+7% +$458K 0.01% 860
2024
Q2 		$6.02M Sell
74,767
-16,889
-18% -$1.25M ﹤0.01% 866
2024
Q1 		$7.31M Buy
91,656
+47,341
+107% +$3.97M 0.01% 849
2023
Q4 		$3.53M Buy
+44,315
New +$2.96M ﹤0.01% 994
2020
Q4 		– Sell
-34,500
Closed -$2.46M – 1677
2020
Q3 		$2.46M Buy
34,500
+7,000
+25% +$545K ﹤0.01% 1026
2020
Q2 		$2.26M Buy
27,500
+11,000
+67% +$847K ﹤0.01% 984
2020
Q1 		$971K Sell
16,500
-3,500
-18% -$285K ﹤0.01% 1103
2019
Q4 		$2.07M Sell
20,000
-12,900
-39% -$521K ﹤0.01% 1023
2019
Q3 		$666K Buy
32,900
+3,500
+12% +$89.9K ﹤0.01% 1222
2019
Q2 		$757K Sell
29,400
-12,600
-30% -$253K ﹤0.01% 1207
2019
Q1 		$598K Buy
+42,000
New +$390K ﹤0.01% 1214

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group's AXSM Position: Q1 2026 in Review

Neuberger Berman Group reduced its Axsome Therapeutics (AXSM) stake by 13% in Q1 2026, selling an estimated $1.51M and leaving 60,759 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #809.

Neuberger Berman Group first reported a position in AXSM in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.7M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Neuberger Berman Group held 60,759 shares of Axsome Therapeutics worth $10.3M as of Q1 2026.
  • Neuberger Berman Group sold 8,724 Axsome Therapeutics shares in Q1 2026, an estimated $1.51M.
  • Axsome Therapeutics made up 0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #809 holding.
  • Neuberger Berman Group first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • Neuberger Berman Group's Axsome Therapeutics position peaked at $12.7M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.